Drug Shortage Report for PROTAMINE SULFATE INJECTION, USP
Report ID | 150090 |
Drug Identification Number | 02139537 |
Brand name | PROTAMINE SULFATE INJECTION, USP |
Common or Proper name | Protamine Sulfate Injection, USP 10 mg/mL SD Vial 5 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | PROTAMINE SULFATE |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 5 mL |
ATC code | V03AB |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-11-26 |
Actual start date | 2021-11-26 |
Estimated end date | 2021-12-29 |
Actual end date | 2021-12-24 |
Shortage status | Resolved |
Updated date | 2021-12-25 |
Company comments | We are pleased to advise that our Protamine Sulfate Injection, USP 10 mg/mL SD Vial 25 mL will be available at Ontario distribution centres effective November 30, 2021, and at all other distribution centres by December 2, 2021. The product will be available for substitution during the backorder of the 5 mL. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-12-25 | English | Compare |
v5 | 2021-12-22 | French | Compare |
v4 | 2021-12-22 | English | Compare |
v3 | 2021-11-27 | English | Compare |
v2 | 2021-11-26 | French | Compare |
v1 | 2021-11-26 | English | Compare |
Showing 1 to 6 of 6